Huggins, K., Datta, S., Soldano, K., Silas, D. P., Elhassan, E. A., Chryst-Stangl, M., … Lane, B. M. (2022). RCAN1 I162T Variant Disrupts Calcineurin Regulation and Reduces Viability in Patient-Derived Podocytes. In JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (Vol. 33, pp. 41–41).

Huggins, Kinsie, Somenath Datta, Karen Soldano, Daniel P. Silas, Elhussein A. Elhassan, Megan Chryst-Stangl, Guanghong Wu, et al. “RCAN1 I162T Variant Disrupts Calcineurin Regulation and Reduces Viability in Patient-Derived Podocytes.” In JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 33:41–41, 2022.

Huggins K, Datta S, Soldano K, Silas DP, Elhassan EA, Chryst-Stangl M, et al. RCAN1 I162T Variant Disrupts Calcineurin Regulation and Reduces Viability in Patient-Derived Podocytes. In: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022. p. 41–41.

Huggins, Kinsie, et al. “RCAN1 I162T Variant Disrupts Calcineurin Regulation and Reduces Viability in Patient-Derived Podocytes.” JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 33, no. 11, 2022, pp. 41–41.

Huggins K, Datta S, Soldano K, Silas DP, Elhassan EA, Chryst-Stangl M, Wu G, Olabisi OA, Conlon PJ, Gbadegesin RA, Lane BM. RCAN1 I162T Variant Disrupts Calcineurin Regulation and Reduces Viability in Patient-Derived Podocytes. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2022. p. 41–41.